​​​​​​​PEG-BIO Biopharm Co.,Ltd(chongqing).
News Center
Home >> 行业动态 >> The 2020 edition of pharmacopoeia biological products to add 40 species
The 2020 edition of pharmacopoeia biological products to add 40 species
Source:医药网 | Author:pro954f45 | Published time: 2018-08-14 | 699 Views | Share:
    According to the work of the national pharmacopoeia committee deployment, according to the "Chinese pharmacopoeia" 2020 edition outline variety selection principles, after the 11th pharmacopoeia committee related professional committee deliberation, through the "Chinese pharmacopoeia" 2020 edition of the three proposed new varieties (biological products) selection. On August 13, the national pharmacopoeia commission announced on its website the new varieties of three biological products to be added to the 2020 edition of the Chinese pharmacopoeia. The publicity period began three months after the date of going online.
    China pharmacopoeia 2020 edition three (biological products) to add new species list
    1.Recombinant hepatitis e vaccine (escherichia coli)
    2.Lyophilized rabies vaccine for humans (human diploid cells)
    3.Live attenuated yellow fever vaccine
    4.Type of oral Ⅰ Ⅲ poliomyelitis live attenuated (human diploid cells)
    5.Inactivated vaccine against the Sabin strain of polio
    6.Inactivated vaccine of enterovirus 71 (human diploid cell)
    7.Inactivated vaccine of enterovirus 71 (Vero cells)
    8.23 valent pneumococcal polysaccharide vaccine
    9.Combined vaccine of hemophilus influenzae type b without cell break
    10.Lyophilized human thrombin
    11.Pig fibrin adhesive
    12.Equine tetanus immunoglobulin [F (ab ') 2]
    13.Diagnostic kit of human immunodeficiency virus antigen antibody (elisa)
    14.Nucleic acid testing kits for hepatitis b virus, hepatitis c virus and human immunodeficiency virus
    15.BCG vaccine for treatment
    16.Recombinant human granulocyte macrophage stimulating factor gel for external use (further confirmation of clinical use)
    17.Recombinant interferon benzoate plus 2a ointment
    18.Recombinant human interferon beam 2b vaginal effervescent capsule
    19.Recombinant human interferon leubrium leubrium leubrium leubrium leubrium vaginal effervescent tablet
    20.The reorganization for injection type Ⅱ tumor necrosis factor receptor - antibody fusion protein
    21.Kombuship eye injection
    22.Lyophilized recombinant human brain natriuretic peptide
    23.Recombinant human tissue plasminogen kinase derivatives for injection
    24.Recombinant human thrombogenin injection
    25.Recombinant human growth hormone for injection
    26.Recombinant human growth hormone injection
    27.Recombinant human follicle-stimulating hormone for injection
    28.Recombinant insulin glargine
    29.Recombinant insulin glargine injection
    30.Recombinant human insulin
    31.Recombinant human insulin injection
    32.Refined protein recombinant human insulin injection
    33.Mixed injection of refined protein recombinant human insulin (30/70)
    34.30/70 mixed recombinant human insulin injection
    35.50/50 mixed recombinant human insulin injection
    36.Mixed injection of refined protein recombinant human insulin (50/50)
    37.Mixed injection of refined protein recombinant human insulin (40/60)
    38.Recombinant lysol insulin
    39.Recombinant lysol insulin injection
    40.Mixed injection of refined protein zinc recombinant lysol insulin (25R)